Jeffrey Chodakewitz

Insider Reports History

Entity
Individual
Location
C/O Tetraphase Pharmaceuticals, Inc., 480 Arsenal St., Suite 101, Watertown, MA
Signature
/s/ Nick Harvey, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey Chodakewitz:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Schrodinger, Inc. Director Common Stock 11.3K $48.8K $4.34 Jun 18, 2024 Direct
Adicet Bio, Inc. Director Common Stock 11.8K $16.9K $1.43 Jun 5, 2024 Direct
Adicet Bio, Inc. Director Stock Option (Right to Buy) 26.4K Aug 21, 2024 Direct
Praxis Precision Medicines, Inc. Director Stock Option (Right to Buy) 8.57K Jun 5, 2024 Direct
Schrodinger, Inc. Director Stock Option (right to buy) 8.55K Jun 18, 2024 Direct

Insider Reports Filed by Jeffrey Chodakewitz

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACET Adicet Bio, Inc. Aug 21, 2024 8 $0 4 Aug 23, 2024 Director
SDGR Schrodinger, Inc. Jun 18, 2024 2 $0 4 Jun 20, 2024 Director
ACET Adicet Bio, Inc. Jun 5, 2024 2 $0 4 Jun 7, 2024 Director
PRAX Praxis Precision Medicines, Inc. Jun 5, 2024 1 $0 4 Jun 6, 2024 Director
ACET Adicet Bio, Inc. Aug 14, 2023 8 $0 4 Aug 16, 2023 Director
SDGR Schrodinger, Inc. Jun 15, 2023 2 $0 4 Jun 16, 2023 Director
PRAX Praxis Precision Medicines, Inc. Jun 12, 2023 1 $0 4 Jun 14, 2023 Director
ACET Adicet Bio, Inc. Jun 1, 2023 2 $0 4 Jun 2, 2023 Director
SDGR Schrodinger, Inc. Jun 15, 2022 1 $0 4 Jun 16, 2022 Director
ACET Adicet Bio, Inc. Jun 2, 2022 1 $0 4 Jun 3, 2022 Director
PRAX Praxis Precision Medicines, Inc. May 26, 2022 1 $0 4 May 27, 2022 Director
SDGR Schrodinger, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director